Moderna Prices Upsized $2.6 Billion Zero-Coupon Convertible Note Offering
Moderna increased its 2032 convertible-note sale from $2.0 billion to $2.6 billion, with net proceeds expected to support general corporate purposes after funding a $285 million capped-call hedge.